verified SJR 1,864 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Biotechnology lock Subscription

Current Opinion in Biotechnology

Current Opinion in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 247. It has a price of 2100 €. It has an SJR impact factor of 1,864 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,864.

Current Opinion in Biotechnology focuses its scope in these topics and keywords: plant, metabolic, expression, protein, systems, engineering, bacteria, design, aerobic, future, ...

ISSN: 0958-1669

Publisher: Elsevier Ltd

Category: Biotechnology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,864 Q1

H-index 247

Acceptance rate pie_chart

19% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.100 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,864

H-index

247

Docs (year)

156

Docs 3y

536

Total refs

9641

Cites 3y

4407

Citable 3y

512

Cites/Doc 2y

7.81

Ref/Doc

61.8

Immediate OA

2100 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Potential applications of DNA microarrays in biodefense-related diagnostics

Mammals, plants, bacteria, and soil: common problems and solutions in gene expression and analysis

Neutron scattering: good news for biotechnology

NMR spectroscopy in structure-based drug design

NMR tools for biotechnology

Paper alert: Biotechnology

Pharmaceutical biotechnology

Pharmaceutical provisions of the FDA modernization act of 1997: one year and counting

Plant biotechnology

Plant biotechnology Biochemical engineering

Plant concepts for mineral acquisition and allocation

Plant-insect interactions: molecular approaches to insect resistance

SHOW MORE ARTICLES

Light at the end of the tunnel: from genes to function

Progress in plant metabolic engineering

Protein engineering in bioelectrocatalysis

Protein technologies and commercial enzymes

Public reactions and scientific responses to transgenic cropsCommentary

Regulatory affairs regulatory frameworks and decisions matter to the development of biotechnology and the approvals for biotechnology products

Structures of redox enzymes

The past and future of structure databases

tRNA-mediated protein engineering

Understanding and modulating apoptosis in industrial cell culture

VEGF and therapeutic opportunities in cardiovascular diseases

Engineering the mouse genome by site-specific recombination

FAQs

Current Opinion in Biotechnology has an SJR of 1,864 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2100 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Current Opinion in Biotechnology is 19%.

Current Opinion in Biotechnology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Opinion in Biotechnology?

What is the APC / publication cost?

What is the acceptance rate?